1. Home
  2. CARM vs ABLV Comparison

CARM vs ABLV Comparison

Compare CARM & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • ABLV
  • Stock Information
  • Founded
  • CARM 2016
  • ABLV 2015
  • Country
  • CARM United States
  • ABLV China
  • Employees
  • CARM N/A
  • ABLV N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • ABLV
  • Sector
  • CARM Health Care
  • ABLV
  • Exchange
  • CARM Nasdaq
  • ABLV Nasdaq
  • Market Cap
  • CARM 41.5M
  • ABLV 38.1M
  • IPO Year
  • CARM N/A
  • ABLV N/A
  • Fundamental
  • Price
  • CARM $0.94
  • ABLV $0.88
  • Analyst Decision
  • CARM Strong Buy
  • ABLV
  • Analyst Count
  • CARM 3
  • ABLV 0
  • Target Price
  • CARM $12.67
  • ABLV N/A
  • AVG Volume (30 Days)
  • CARM 183.3K
  • ABLV 12.9K
  • Earning Date
  • CARM 11-07-2024
  • ABLV 01-01-0001
  • Dividend Yield
  • CARM N/A
  • ABLV N/A
  • EPS Growth
  • CARM N/A
  • ABLV 18.07
  • EPS
  • CARM N/A
  • ABLV 0.24
  • Revenue
  • CARM $20,268,000.00
  • ABLV $148,999,819.00
  • Revenue This Year
  • CARM $50.40
  • ABLV N/A
  • Revenue Next Year
  • CARM N/A
  • ABLV N/A
  • P/E Ratio
  • CARM N/A
  • ABLV $3.66
  • Revenue Growth
  • CARM 41.13
  • ABLV 2.58
  • 52 Week Low
  • CARM $0.80
  • ABLV $0.67
  • 52 Week High
  • CARM $3.16
  • ABLV $3.94
  • Technical
  • Relative Strength Index (RSI)
  • CARM 40.39
  • ABLV 42.79
  • Support Level
  • CARM $0.96
  • ABLV $0.82
  • Resistance Level
  • CARM $1.01
  • ABLV $0.94
  • Average True Range (ATR)
  • CARM 0.06
  • ABLV 0.05
  • MACD
  • CARM -0.01
  • ABLV 0.00
  • Stochastic Oscillator
  • CARM 4.74
  • ABLV 35.67

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

Share on Social Networks: